Oppenheimer Inc. (OPY)
NYSE: OPY
· Real-Time Price · USD
66.11
0.35 (0.53%)
At close: Jun 27, 2025, 3:59 PM
67.50
2.11%
After-hours: Jun 27, 2025, 05:29 PM EDT
0.53% (1D)
| Bid | 63.04 |
| Market Cap | 689.2M |
| Revenue (ttm) | 1.45B |
| Net Income (ttm) | 76.16M |
| EPS (ttm) | 6.82 |
| PE Ratio (ttm) | 9.69 |
| Forward PE | 79.43 |
| Analyst | n/a |
| Ask | 68 |
| Volume | 40,215 |
| Avg. Volume (20D) | 57,091 |
| Open | 65.63 |
| Previous Close | 65.76 |
| Day's Range | 65.24 - 66.25 |
| 52-Week Range | 46.91 - 73.12 |
| Beta | 1.20 |
2 months ago
+0.9%
Shares of financial companies are trading higher a...
Unlock content with
Pro Subscription
2 months ago
+1.78%
Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.
2 weeks ago · https://thefly.com
UroGen Pharma price target raised to $31 from $10 at OppenheimerOppenheimer analyst Leland Gershell raised the firm's price target on UroGen Pharma to $31 from $10 and keeps an Outperform rating on the shares following yesterday's approval of Zusduri. The firm say...
2 weeks ago · https://www.defenseworld.net
Squarepoint Ops LLC Buys New Position in Abeona Therapeutics Inc (NASDAQ:ABEO)Squarepoint Ops LLC bought a new position in Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securitie...
